{"transactions":[{"id":694350,"issuer":{"id":6633,"kind":"organization","name":"Quantum Cyber N.V."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-06T23:51:36.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":112859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The purpose of this Form 4/A is to correct (i) the date of the reported transaction, (ii) the quantity of securities acquired by the Reporting Person, and (iii) the quantity of securities beneficially owned by the Reporting Person following the reported transaction."},{"field":"shares","element":"transactionShares","label":"F1","text":"The purpose of this Form 4/A is to correct (i) the date of the reported transaction, (ii) the quantity of securities acquired by the Reporting Person, and (iii) the quantity of securities beneficially owned by the Reporting Person following the reported transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The purpose of this Form 4/A is to correct (i) the date of the reported transaction, (ii) the quantity of securities acquired by the Reporting Person, and (iii) the quantity of securities beneficially owned by the Reporting Person following the reported transaction."}],"balance_after":252000,"source":{"system":"sec-edgar","filing":"0001213900-26-086310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000121390026086310/ownership.xml","form_type":"4/A","original_submission_date":"2026-08-05"}},{"id":695927,"issuer":{"id":6633,"kind":"organization","name":"Quantum Cyber N.V."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-06T01:35:04.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":112259,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":251400,"source":{"system":"sec-edgar","filing":"0001213900-26-085872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000121390026085872/ownership.xml","form_type":"4"}},{"id":764069,"issuer":{"id":6633,"kind":"organization","name":"Quantum Cyber N.V."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-26T22:12:13.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":137141,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":139141,"source":{"system":"sec-edgar","filing":"0001213900-26-061129","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000121390026061129/ownership.xml","form_type":"4"}},{"id":933500,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy Common Stock","published_at":"2026-01-23T02:57:06.000Z","date":"2025-12-23","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Board through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Board through each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.95,"expiration_date":"2035-12-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-003293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000149315226003293/ownership.xml","form_type":"4"}},{"id":933499,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T02:57:06.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 25,000 shares of restricted common stock of the Issuer pursuant to a consulting agreement dated January 20, 2026, which shares vested 100% upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100 shares of common stock of the Issuer held in a Roth IRA."}],"balance_after":25100,"source":{"system":"sec-edgar","filing":"0001493152-26-003293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000149315226003293/ownership.xml","form_type":"4"}},{"id":1021812,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-10-08T20:21:28.000Z","date":"2025-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on August 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on September 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on September 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on September 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000921895-25-002721","document":"form413531003_10082025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189525002721/form413531003_10082025.xml","form_type":"4"}},{"id":1021811,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-10-08T20:21:28.000Z","date":"2025-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on August 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on August 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on August 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on August 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0000921895-25-002721","document":"form413531003_10082025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189525002721/form413531003_10082025.xml","form_type":"4"}},{"id":1021810,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T20:21:28.000Z","date":"2025-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024 (the \"Merger Agreement\"), by and among Titan Pharmaceuticals, Inc. (\"Titan\"), Black Titan Corporation (\"Black Titan\"), TTNP Merger Sub, Inc., a direct wholly owned subsidiary of Black Titan (\"Merger Sub\") and TalenTec Sdn. Bhd, in exchange for 1 ordinary share of Black Titan common stock for each share of Titan common stock on the effective date of the merger (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000921895-25-002721","document":"form413531003_10082025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189525002721/form413531003_10082025.xml","form_type":"4"}},{"id":1238985,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-02-28T21:47:32.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."}],"balance_after":700000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-02-26","expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0000921895-25-000650","document":"form412227019ben_02282025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000650/form412227019ben_02282025.xml","form_type":"4"}},{"id":1396917,"issuer":{"id":7395,"kind":"organization","name":"FiEE, Inc.","symbol":"FIEE"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T00:31:39.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":159364,"ownership":{"direct":false,"nature":"By: NLT Management and Asset Holding Company LTD"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of restricted stock issued pursuant to the Non-Employee Directors Compensation Plan of Minim, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by NLT Management and Asset Holding Company LTD, an entity owned by the spouse of Mr. Ben-Tzvi in which Mr. Ben-Tzvi has a pecuniary interest."}],"balance_after":159364,"source":{"system":"sec-edgar","filing":"0000921895-24-002201","document":"form412227016ben_10012024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000092189524002201/form412227016ben_10012024.xml","form_type":"4"}},{"id":1542020,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-15T13:07:30.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000921895-24-000834","document":"form412227017ben_04122024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000092189524000834/form412227017ben_04122024.xml","form_type":"4"}},{"id":1672236,"issuer":{"id":7395,"kind":"organization","name":"FiEE, Inc.","symbol":"FIEE"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-24T22:09:37.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of restricted stock issued pursuant to the Non-Employee Directors Compensation Plan of Minim, Inc."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000921895-24-000126","document":"form412227016ben_01242024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944721/000092189524000126/form412227016ben_01242024.xml","form_type":"4"}},{"id":1754885,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-26T16:23:37.000Z","date":"2023-10-25","kind":"grant","planned":false,"acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant."}],"balance_after":66250,"source":{"system":"sec-edgar","filing":"0000921895-23-002392","document":"form413531002ben_10262023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189523002392/form413531002ben_10262023.xml","form_type":"4"}},{"id":1820739,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-07-31T19:38:08.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The options were approved by the Issuer's Board of Directors on September 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on September 15, 2022."},{"field":"date","element":"transactionDate","label":"F3","text":"The options were approved by the Issuer's Board of Directors on September 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were approved by the Issuer's Board of Directors on September 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on September 15, 2022."}],"balance_after":100000,"derivative":{"exercise_price":1.31,"expiration_date":"2032-09-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000921895-23-001765","document":"form413531ben_07282023.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189523001765/form413531ben_07282023.xml","form_type":"4"}},{"id":1820738,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-07-31T19:38:08.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The options were approved by the Issuer's Board of Directors on August 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on August 15, 2022."},{"field":"date","element":"transactionDate","label":"F2","text":"The options were approved by the Issuer's Board of Directors on August 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on August 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were approved by the Issuer's Board of Directors on August 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on August 15, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.52,"expiration_date":"2032-08-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000921895-23-001765","document":"form413531ben_07282023.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189523001765/form413531ben_07282023.xml","form_type":"4"}},{"id":1820737,"issuer":{"id":74432,"kind":"organization","name":"TITAN PHARMACEUTICALS INC","symbol":"TTNP"},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T19:38:08.000Z","date":"2023-07-26","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0000921895-23-001765","document":"form413531ben_07282023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/910267/000092189523001765/form413531ben_07282023.xml","form_type":"4"}}]}